About
Leadership
Board of Directors
Scientific Advisors
Careers
Contact Us
Technology
Publications
Collaborations
Pipeline & Clinical Trials
FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
FCX-013 Gene Therapy for Localized Scleroderma
Gene Therapy Research Program for Arthritis and Related Conditions
Clinical Trials
Investors
Stock Information
News, Events & Presentations
SEC Filings
Corporate Governance
Analyst Coverage
Investor FAQs
Investor Contacts
Patients & Families
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Localized Scleroderma
Arthritis and Related Conditions
News, Events &
Presentations
Contact
Toggle navigation
SEC Filings
Investors
|
SEC Filings
Back
Form 8-K
FIBROCELL SCIENCE, INC. filed this
Form 8-K
on 02/05/2018
Document Outline
Entire Document (3464.7 KB)
Subdocument 1 - 8-K - 8-K
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Subdocument 2 - EX-99.1 - EXHIBIT 99.1
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Subdocument 3 - EX-99.2 - EXHIBIT 99.2
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
